Pure Global

REJURAN - Dermal tissue reconstructive material, animal-derived

Access comprehensive regulatory information for REJURAN - Dermal tissue reconstructive material, animal-derived in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by K Bridge Medical Pty Ltd, manufactured by PharmaResearch Co Ltd in South Korea. The device registration started on July 05, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
Class III
REJURAN - Dermal tissue reconstructive material, animal-derived
Australia TGA ARTG Registered Device
Good Name: K Bridge Medical Pty Ltd - REJURAN - Dermal tissue reconstructive material, animal-derived
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

REJURAN is an injectable gel which is intended for injection into the mid to deep dermis to promote tissue restoration and reconstruction, and improvement of physical appearance. It is highly versatile and easy to handle and can be used on areas of the face (especially around the eyes, perioral area).

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
July 05, 2023
Effective Date
July 05, 2023
Manufacturer
Country
South Korea
Address
77-19 Gwahakdanji-ro Gangneung-si, Gangwon-do, 25452